Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Interest Expenses (2016 - 2017)

Bone Biologics (BBLG) has disclosed Interest Expenses for 2 consecutive years, with $957062.0 as the latest value for Q2 2017.

  • On a quarterly basis, Interest Expenses rose 165.92% to $957062.0 in Q2 2017 year-over-year; TTM through Dec 2017 was $1.7 million, a 66.58% increase, with the full-year FY2021 number at $805109.0, down 19.33% from a year prior.
  • Interest Expenses was $957062.0 for Q2 2017 at Bone Biologics, up from $762352.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $957062.0 in Q2 2017 to a low of $310089.0 in Q1 2016.